Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case–control study in an Arab Gulf country

[1]  N. Al-Daghri,et al.  Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study , 2020, Cardiovascular Diabetology.

[2]  Liming Cheng,et al.  Vitamin D Deficiency Is Inversely Associated with COVID-19 Incidence and Disease Severity in Chinese People , 2020, The Journal of nutrition.

[3]  N. Al-Daghri,et al.  Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh, Saudi Arabia , 2020, Diabetes Research and Clinical Practice.

[4]  A. Pourfathollah,et al.  Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases , 2020, Microorganisms.

[5]  A. Abrishami,et al.  Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study , 2020, European Journal of Nutrition.

[6]  J. Crespo,et al.  Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection , 2020, The Journal of clinical endocrinology and metabolism.

[7]  Jianfang Liu,et al.  Recent progress of antiviral therapy for coronavirus disease 2019 , 2020, European Journal of Pharmacology.

[8]  Z. Qin,et al.  Does Serum Vitamin D Level Affect COVID-19 Infection and Its Severity?-A Case-Control Study , 2020, Journal of the American College of Nutrition.

[9]  P. Dormitzer,et al.  COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses , 2020, Nature.

[10]  V. Backman,et al.  Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients , 2020, Aging Clinical and Experimental Research.

[11]  Amit Sharma,et al.  Exploring links between vitamin D deficiency and COVID-19 , 2020, PLoS pathogens.

[12]  D. Meltzer,et al.  Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results , 2020, JAMA network open.

[13]  C. Missouris,et al.  Vitamin D status and outcomes for hospitalised older patients with COVID-19 , 2020, Postgraduate medical journal.

[14]  Nabab Khan.  Possible protective role of 17β-estradiol against COVID-19 , 2020, Journal of allergy and infectious diseases.

[15]  E. Medico,et al.  Associations between hypovitaminosis D and COVID-19: a narrative review , 2020, Aging Clinical and Experimental Research.

[16]  S. Del Prato,et al.  COVID-19 in people with diabetes: understanding the reasons for worse outcomes , 2020, The Lancet Diabetes & Endocrinology.

[17]  R. Quinton,et al.  Low serum 25‐hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID‐19 are associated with greater disease severity , 2020, Clinical endocrinology.

[18]  A. Gorohovski,et al.  Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study , 2020, medRxiv.

[19]  Eric J Topol,et al.  Prevalence of Asymptomatic SARS-CoV-2 Infection , 2020, Annals of Internal Medicine.

[20]  Barney S. Graham,et al.  Rapid COVID-19 vaccine development , 2020, Science.

[21]  Lee Smith,et al.  The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality , 2020, Aging Clinical and Experimental Research.

[22]  G. Ippolito,et al.  COVID-19, SARS and MERS: are they closely related? , 2020, Clinical Microbiology and Infection.

[23]  T. Elhadd,et al.  Diagnosis and management of vitamin D deficiency in the Gulf Cooperative Council (GCC) countries: an expert consensus summary statement from the GCC vitamin D advisory board , 2020, Archives of Osteoporosis.

[24]  F. Shokri,et al.  The interplay between vitamin D and viral infections , 2019, Reviews in medical virology.

[25]  John H. White,et al.  Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions , 2018, Endocrine reviews.

[26]  N. Al-Daghri.  Vitamin D in Saudi Arabia: Prevalence,distribution and disease associations , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  J. Reginster,et al.  Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO) , 2016, Archives of Osteoporosis.

[28]  C. Palacios,et al.  Is vitamin D deficiency a major global public health problem? , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  R. Thadhani,et al.  Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). , 2014, BoneKEy reports.

[30]  I. D. de Boer,et al.  Impaired vitamin D metabolism in CKD. , 2013, Seminars in nephrology.

[31]  R. Gama,et al.  Vitamin D: a negative acute phase reactant , 2013, Journal of Clinical Pathology.

[32]  R. Striker,et al.  Vitamin D and the anti-viral state. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[33]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[34]  T. Moriwake,et al.  Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. , 2000, Endocrinology.